Executive Vice President
Overcoming linguistic and cultural barriers
Since Linical was established in 2005, the company has accumulated a wealth of experience, taking on numerous contracts involving clinical trials conducted only in Japan and the Japanese part of international clinical trials. As a result of this track record, in 2014, Linical was awarded a contract for the first Japan-led Asian clinical trial (in the area of oncology), and (as of 2017) the company is currently engaged in multiple Japan-led Asian clinical trials and Japan-USA clinical trials in the areas of oncology, immune system diseases, and other serious conditions. In all of these clinical trials, our project managers remain stationed in Japan as they manage the other participating countries. It is one of our great strengths that through these project managers, our Japanese clients are able to communicate readily with the managers and monitors in each country from within Japan, without needing to overcome linguistic and cultural barriers. The project managers in Japan generally use English to communicate with other countries, but in some cases, they communicate with local monitors in Korean or Chinese, to ensure greater precision and avoid any erroneous or incomplete understanding. Furthermore, without resting on our laurels, we are constantly hiring and training monitors who can speak both English and Japanese. For some individuals, after allowing them to gain experience as a monitor or leader in international clinical trials within Japan, we send them to work at our overseas subsidiaries to accumulate experience as project managers. In this way, we actively foster the development of project managers with global awareness and capabilities.
We expect that more and more Japanese-led international clinical trials will be conducted in the coming years. As our Japanese personnel take on more responsibility for the management of international pharmaceutical projects, they will rightly feel a sense of pride. Linical has developed a global system capable of delivering a one-stop set of comprehensive services to meet the wide-ranging needs of clients — from regulatory affairs, to the planning and development of clinical trial protocols, monitoring, data management, biostatistics analysis, and pharmacovigilance. We believe that as a Japan-Headquartered Global CRO, we can offer unrivalled partnership to clients that wish to implement Japan-led clinical trials in other countries. Please feel free to consult with us about your needs and requirements.